CTD 6.25 Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Chlorthalidone (6.25mg)
Overview CTD 6.25 Tablet
Cetrax 6.25mg tablets function as a diuretic, effectively managing hypertension by eliminating excess bodily fluid. This medication addresses edema stemming from cardiac, hepatic, renal, or pulmonary conditions, promoting fluid excretion via urination. Cetrax 6.25mg may be administered independently or alongside other therapies, ideally during daylight hours to minimize nocturnal urination. Adherence to the prescribed dosage and duration is crucial; abrupt cessation requires medical consultation. While hypertension often presents asymptomatically, discontinuation can exacerbate the condition, potentially increasing the risk of cardiovascular events. Regular blood pressure monitoring is essential. This medication complements a holistic approach encompassing balanced nutrition, physical activity, smoking cessation, responsible alcohol consumption, and weight management. Maintain a normal diet, though sodium reduction is advisable. Headache, nausea, and dizziness are potential side effects; consult your physician if these persist. Prior to commencement, disclose any renal or hepatic ailments, and pregnant or lactating individuals should seek medical guidance. Comprehensive disclosure of all concurrent medications is vital.
Uses of CTD 6.25 Tablet
Managing elevated blood pressure and fluid retention.
Major Benefits of CTD 6.25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume CTD 6.25 Tablet with a meal.
Common Side effects of CTD 6.25 Tablet:
- Headache
- Nausea
- Dizziness
How to use CTD 6.25 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The CTD 6.25 Tablet should be administered with a meal.
How CTD 6.25 Tablet works:
Each CTD 6.25 mg tablet acts as a diuretic, reducing blood pressure through the excretion of excess fluid and electrolytes. Its sustained use also promotes vasodilation and enhanced circulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of CTD 6.25 Tablet and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of CTD 6.25 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCAUTION
The use of CTD 6.25 Tablet while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system. The drug's slow elimination rate poses a risk of accumulation in the nursing infant.
DrivingUNSAFE
Taking a 6.25 mg CTD tablet could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from driving if these effects arise.
KidneyCAUTION
Patients with severe renal impairment should exercise caution when using CTD 6.25 Tablet, potentially requiring dosage modification. Physician consultation is advised. CTD 6.25 Tablet is contraindicated in such individuals.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using CTD 6.25 Tablets; dosage modification may be necessary. A physician's consultation is advised. CTD 6.25 Tablets are contraindicated in individuals with severe liver dysfunction.
What if you forget to take CTD 6.25 Tablet :
Should you forget to take a CTD 6.25 Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About CTD 6.25 Tablet
| Label | Value |
|---|---|
| Chemical Category | Thiazide diuretics and related heterocyclic compounds |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Category | Sodium-Chloride Symporter Inhibitors (Low-Ceiling Diuretics) |
3,018 People bought this recently